Welcome to our dedicated page for Castellum SEC filings (Ticker: CTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Castellum Inc’s rapid string of cybersecurity and electronic-warfare acquisitions means every new 10-K and 10-Q feels like a puzzle of contract clauses, backlog shifts, and earn-out schedules. If tracking cleared-executive sales or decoding fresh Department of Defense awards has you buried in PDFs, you’re not alone.
Stock Titan solves that problem. Our AI engine parses every Castellum Inc quarterly earnings report 10-Q filing and the sprawling annual report 10-K simplified into clear takeaways—think revenue by mission area, goodwill amortization, and pipeline updates without the jargon. Need Castellum Inc insider trading Form 4 transactions the moment they hit EDGAR? We deliver Form 4 insider transactions real-time, flag unusual buys, and link them to 8-K material events explained. You can even ask natural questions such as “understanding Castellum Inc SEC documents with AI” or “Castellum Inc proxy statement executive compensation” and receive instant, plain-English answers.
- Monitor Castellum Inc executive stock transactions Form 4 alongside backlog disclosures to spot confidence signals.
- Compare cybersecurity margin trends across periods with our Castellum Inc earnings report filing analysis dashboard.
- Set custom alerts for each Castellum Inc 8-K so material contract wins or impairment charges never slip past you.
Every filing—10-K, 10-Q, 8-K, S-1, DEF 14A, plus Castellum Inc insider trading Form 4 transactions—is updated in real time and paired with AI-powered summaries that explain filing meanings in simple terms. Skip the 300-page read and go straight to the numbers, risks, and insider moves that matter.
Castellum, Inc. (CTM) filed a Form 144 notifying the proposed sale of 500,000 shares of Common Stock through First Georgetown Securities Inc with an aggregate market value of $640,000 and an approximate sale date of 08/18/2025 on the NYSE. The filing lists total shares outstanding of 930,900,584. It discloses the acquisition history for the securities to be sold: purchases and conversions on 07/22/2019, 05/02/2020, and a merger-related acquisition on 06/10/2019, totaling recorded amounts of 168,215, 305,000, and 26,785 shares respectively. The filer also reported a sale on 05/19/2025 of 259,400 shares for gross proceeds of $278,673.20. The filer attests there is no undisclosed material adverse information.
Form 144 notice for Castellum, Inc. (CTM): The filer intends to sell 500,000 shares of common stock through First Georgetown Securities Inc. on the NYSE, with an approximate sale date of 08/18/2025 and an aggregate market value listed at $640,000.00. The filing shows 930,900,584 shares outstanding. The shares were acquired in a private placement from Castellium Inc. (acquisition dated 06/15/2019) and the payment is recorded as cash on 06/14/2019. The filing also discloses a sale on 05/19/2025 of 500,000 shares for gross proceeds of $518,025.48. The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.
Castellum, Inc. reported that purchasers exercised 3,673,666 warrants, resulting in the issuance of 3,673,666 shares of common stock and total gross proceeds of $4,481,873. The exercises were conducted pursuant to prior agreements and the company agreed to pay Maxim Group LLC a cash placement fee equal to 3.5% of the aggregate proceeds, totaling $156,866. The company issued a press release on August 14, 2025 announcing these warrant exercises and filed that release as Exhibit 99.1.
The disclosure is limited to the aggregate exercise, proceeds received, and the placement agent fee; no additional financial statements, use of proceeds, or effects on outstanding share count beyond the issued shares are provided in this filing.
Castellum, Inc. furnished a current report stating it has issued a press release announcing financial results for the three months ended June 30, 2025. The press release is attached to the filing as Exhibit 99.1 and the filing also references an interactive data file as Exhibit 104. The registrant's common stock trades under the symbol CTM on NYSE American.
The 8-K provides notice that the press release contains the reported results but does not include the financial figures within the body of the filing. The company states this information is being furnished under Item 2.02 and is not being treated as filed or incorporated by reference into other securities filings except by specific reference.
Castellum, Inc. reported quarterly revenue of $14.02 million and six‑month revenue of $25.69 million, increases of 22% and 12% year‑over‑year, driven largely by a $103.3 million GTMR contract award and organic labor growth. Gross profit rose to $5.06 million for the quarter and $9.62 million for six months, while net loss narrowed to $0.35 million for the quarter and $1.55 million for six months.
Liquidity strengthened with cash of $14.73 million at June 30, 2025 and total liabilities reduced to $11.67 million, reflecting repayment of the revolver and principal paydowns on notes. Backlog totaled $201.99 million (funded $18.35 million, unfunded $22.45 million, priced options $161.19 million), with management expecting ~22% to be recognized within 12 months. Key risks noted in the filing include heavy customer concentration (three government customers represented 70% of revenue) and a significant accumulated deficit of $(55.63) million.
Castellum, Inc. (CTM) – Form 8-K key points
• On 4 Aug 2025 the company signed a letter agreement with Emil Kaunitz to extend the $400,000 note to 1 Mar 2026. Beginning March, the principal will amortize at $50,000 per month for eight months. All other terms of the note are unchanged.
• The same day, Castellum prepaid $2 million of principal on the Robert Eisiminger note, reducing the balance to $2 million while keeping the 31 Aug 2026 maturity intact. A press release (Exhibit 99.1) covers the transaction.
These actions decrease total debt by $2 million and smooth near-term maturities, suggesting stronger liquidity management. No earnings, equity, or guidance updates accompanied the filing.